Related Experiment Video
Updated: May 24, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
von Willebrand factor, shear stress, and ADAMTS13 in hemostasis and thrombosis
1Section of Hemostasis and Thrombosis, Pennsylvania State University Milton S. Hershey College of Medicine, Hershey, USA. htsai@hmc.psu.edu
von Willebrand factor (VWF), an adhesive glycoprotein whose deficiency is best known for causing bleeding in patients with von Willebrand disease (VWD), is a complex molecule with a myriad of mysterious properties including its dependence on shear stress for adhesive functions. The discovery of ADAMTS13 has provided a critical impetus for understanding the regulation of VWF activity by shear stress. This communication reviews the current knowledge in VWF homeostasis and illustrates how this knowledge may help understand the changes affecting patients with various conditions including thrombotic thrombocytopenic purpura, VWD, hemolytic uremic syndrome, aortic stenosis, and ventricular assist devices.
von Willebrand factor (VWF), an adhesive glycoprotein whose deficiency is best known for causing bleeding in patients with von Willebrand disease (VWD), is a complex molecule with a myriad of mysterious properties including its dependence on shear stress for adhesive functions. The discovery of ADAMTS13 has provided a critical impetus for understanding the regulation of VWF activity by shear stress. This communication reviews the current knowledge in VWF homeostasis and illustrates how this knowledge may help understand the changes affecting patients with various conditions including thrombotic thrombocytopenic purpura, VWD, hemolytic uremic syndrome, aortic stenosis, and ventricular assist devices.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Vascular Spasm
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

